TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Photocure ASA ( (PHCUF) ) has provided an update.
Photocure ASA has granted 348,000 share options to its employees, constituting approximately 1.28% of the total shares issued, as part of its long-term incentive program. This move, which includes options for key executives, aims to align employee interests with company growth, while also resetting the vesting period for certain options, potentially enhancing stakeholder value.
More about Photocure ASA
Photocure ASA, known as The Bladder Cancer Company, specializes in delivering transformative solutions for bladder cancer patients. Their unique technology enhances cancer detection by making cancer cells glow bright pink, improving health outcomes globally. The company is headquartered in Oslo, Norway, and is listed on the Oslo Stock Exchange.
YTD Price Performance: -4.35%
Average Trading Volume: 49,559
Current Market Cap: NOK1.61B
For a thorough assessment of PHCUF stock, go to TipRanks’ Stock Analysis page.